Human Cytomegalovirus Primary Infection and Reactivation: Insights From Virion-Carried Molecules
- PMID: 32765441
- PMCID: PMC7378892
- DOI: 10.3389/fmicb.2020.01511
Human Cytomegalovirus Primary Infection and Reactivation: Insights From Virion-Carried Molecules
Abstract
Human cytomegalovirus (HCMV), a ubiquitous beta-herpesvirus, is able to establish lifelong latency after initial infection. Periodical reactivation occurs after immunosuppression, remaining a major cause of death in immunocompromised patients. HCMV has to reach a structural and functional balance with the host at its earliest entry. Virion-carried mediators are considered to play pivotal roles in viral adaptation into a new cellular environment upon entry. Additionally, one clear difference between primary infection and reactivation is the idea that virion-packaged factors are already formed such that those molecules can be used swiftly by the virus. In contrast, virion-carried mediators have to be transcribed and translated; thus, they are not readily available during reactivation. Hence, understanding virion-carried molecules helps to elucidate HCMV reactivation. In this article, the impact of virion-packaged molecules on viral structure, biological behavior, and viral life cycle will be reviewed.
Keywords: HCMV; envelope; primary infection; reactivation; tegument; virion-carried molecules.
Copyright © 2020 Wang and Zhao.
Figures
Similar articles
-
Human Cytomegalovirus Enters the Primary CD34+ Hematopoietic Progenitor Cells Where It Establishes Latency by Macropinocytosis.J Virol. 2019 Jul 17;93(15):e00452-19. doi: 10.1128/JVI.00452-19. Print 2019 Aug 1. J Virol. 2019. PMID: 31118259 Free PMC article.
-
Reactivation of human cytomegalovirus in dendritic cells.Discov Med. 2005 Apr;5(26):170-4. Discov Med. 2005. PMID: 20704905
-
Human Cytomegalovirus Latency and Reactivation in Allogeneic Hematopoietic Stem Cell Transplant Recipients.Front Microbiol. 2019 May 28;10:1186. doi: 10.3389/fmicb.2019.01186. eCollection 2019. Front Microbiol. 2019. PMID: 31191499 Free PMC article. Review.
-
Human cytomegalovirus exploits interferon-induced transmembrane proteins to facilitate morphogenesis of the virion assembly compartment.J Virol. 2015 Mar;89(6):3049-61. doi: 10.1128/JVI.03416-14. Epub 2014 Dec 31. J Virol. 2015. PMID: 25552713 Free PMC article.
-
[Cytomegalovirus (CMV)].Uirusu. 2010 Dec;60(2):209-20. doi: 10.2222/jsv.60.209. Uirusu. 2010. PMID: 21488334 Review. Japanese.
Cited by
-
Dual inhibition of innate immunity and apoptosis by human cytomegalovirus protein UL37x1 enables efficient virus replication.Nat Microbiol. 2022 Jul;7(7):1041-1053. doi: 10.1038/s41564-022-01136-6. Epub 2022 May 30. Nat Microbiol. 2022. PMID: 35637330
-
Detection of Human cytomegalovirus UL55 Gene and IE/E Protein Expression in Colorectal Cancer Patients in Egypt.BMC Cancer. 2023 Aug 3;23(1):723. doi: 10.1186/s12885-023-11200-x. BMC Cancer. 2023. PMID: 37537552 Free PMC article.
-
Structural and Synthetic Aspects of Small Ring Oxa- and Aza-Heterocyclic Ring Systems as Antiviral Activities.Viruses. 2023 Aug 28;15(9):1826. doi: 10.3390/v15091826. Viruses. 2023. PMID: 37766233 Free PMC article. Review.
-
Human Cytomegalovirus IE2 Both Activates and Represses Initiation and Modulates Elongation in a Context-Dependent Manner.mBio. 2022 Jun 28;13(3):e0033722. doi: 10.1128/mbio.00337-22. Epub 2022 May 17. mBio. 2022. PMID: 35579393 Free PMC article.
-
EPHA2 Receptor as a Possible Therapeutic Target in Viral Infections.Curr Med Chem. 2024;31(35):5670-5701. doi: 10.2174/0109298673256638231003111234. Curr Med Chem. 2024. PMID: 37828671 Review.
References
-
- Ahn J. H., Jang W. J., Hayward G. S. (1999). The human cytomegalovirus IE2 and UL112-113 proteins accumulate in viral DNA replication compartments that initiate from the periphery of promyelocytic leukemia protein-associated nuclear bodies (PODs or ND10). J. Virol. 73 10458–10471. 10.1128/jvi.73.12.10458-10471.1999 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources